In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

European Heart Journal - Cardiovascular Pharmacotherapy

Cardiovascular Pharmacology and Pharmacotherapy

Specific focus on clinical cardiovascular pharmacology

Why a new journal?

Pharmacology is an extremely important part of cardiology today. Nearly every patient with cardiac disease is on some kind of medication. Already there are almost half a million references to ‘cardiovascular pharmacology’ in MEDLINE and the number of papers within this area is growing very fast. More studies are needed to improve outcomes of patients with cardiovascular disease, which is the most common cause of death globally.

Mission Statement:

The official journal of the ESC Working Group on Cardiovascular Pharmacotherapy and a brand new addition to the ESC Journal Family, EHJ - Cardiovascular Pharmacotherapy aims to publish reports specifically describing clinical research relevant to cardiovascular drug therapy.

Contribute to the success of this brand new journal

Submit your paper

Visit the journal's home page 

EHJ: Cardiovascular Pharmacotherapy information

ISSN 2055-6837
Volume 3 - year 2017
4 issues

2017 Public price

173 EUR

2017 Special rates

Members of the Working Group on Cardiovascular Pharmacotherapy
Online: access included in the Membership
Combined (print & online): 103.80 EUR

ESC Constituent Bodies Members
Combined (print & online): 103.80 EUR

ESC Professional/ Professional Plus Members
Combined (print & online): 77.85 EUR

Subscribe here


Professor Stefan Agewall, (NO), MD PhD, FESC, FACC, is a senior consultant and professor of cardiology at Oslo University Hospital. More than 170 peer-reviewed publications in the cardiovascular field. Chairman of the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology 2014-2016. Senior Consulting Editor of the European Heart Journal. Board member of the European Society of Cardiology Committee for Practice Guidelines and Editorial board member of the European Heart Journal.